The genetic basis of idiopathic pulmonary fibrosis

Kropski Jonathan A., Blackwell Timothy S., Loyd James E.

Source: Eur Respir J 2015; 45: 1717-1727
Journal Issue: June
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kropski Jonathan A., Blackwell Timothy S., Loyd James E.. The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J 2015; 45: 1717-1727

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic susceptibility and pulmonary fibrosis
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005

Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 538-552
Year: 2016



Novel rare genetic variants in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020
Year: 2020



Towards a better diagnosis of idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 108-113
Year: 2011



PP217 – Modeling idiopathic pulmonary fibrosis on a lung-on-chip
Source: ERS Lung Science Conference 2021
Year: 2021

The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012

Combined idiopathic pulmonary fibrosis and emphysema: functional characterization
Source: Eur Respir J 2004; 24: Suppl. 48, 283s
Year: 2004

Immunogenetic background of children´s idiopathic interstitial pneumonias and adult idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018
Year: 2018



A first step against idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2011; 20: 130-131
Year: 2011


Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis
Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017
Year: 2017



Comparison of clinical characteristics and prognosis in patients with idiopathic pulmonary upper lobe predominant pulmonary fibrosis and idiopathic pulmonary fibrosis
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Evaluating disease severity in idiopathic pulmonary fibrosis
Source: Eur Respir Rev, 26 (145) 170051; 10.1183/16000617.0051-2017
Year: 2017



Current and future therapeutic approaches in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 26: 693-703
Year: 2005



The changing treatment landscape in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2015; 24: 65-68
Year: 2015



Significance of histopathologic features suggesting connective tissue disease in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour
Source: Eur Respir J 2007; 30: Suppl. 51, 488s
Year: 2007

Genetics in idiopathic pulmonary fibrosis
Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine
Year: 2016


Genetic predictors of idiopathic pulmonary fibrosis (IPF) prognosis
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006